Contributor #J-7530
Anonymous submitter. Repair class, high cadence, low commentary.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.05%
n=6
Suppliers covered
6
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041612 | TB-500 | FGP | FGP-2512-Y7789 | Janoshik | 2026-Q2 | 99.93 | 4.39 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021045 | Gonadorelin | BCH | BCH-2510-F4167 | Medutest | 2025-Q4 | 98.88 | 5.10 | 99.9 | Buyer-sourced | 0 | PASS |
| AX-2025-019992 | Semaglutide | SWB | SWB-2504-Y6911 | VendorInvestigate | 2025-Q3 | 99.19 | 2.67 | 93.1 | Buyer-sourced | 0 | PASS |
| AX-2025-019226 | Enclomiphene citrate | SinoPep | SNP-2503-J5227 | Medutest | 2025-Q3 | 98.63 | 4.69 | 91.6 | Buyer-sourced | 1 | FAIL |
| AX-2025-019543 | CJC-1295 (no DAC) | TFC | TFC-2411-M9928 | Janoshik | 2025-Q2 | 98.91 | 2.25 | 106.0 | Buyer-sourced | 1 | FAIL |
| AX-2025-019834 | Survodutide | Homopeptide | HOMO-2406-F5091 | Janoshik | 2024-Q4 | 99.70 | 4.86 | 96.5 | Buyer-sourced | 0 | PASS |